Tofacitinib Impurity 45 manufacturers
- Tofacitinib Impurity
-
-
2025-12-16
- CAS:2407039-29-4
- Min. Order: 10mg
- Purity: 99%+ HPLC
- Supply Ability: 1000
|
| | Tofacitinib Impurity 45 Basic information |
| Product Name: | Tofacitinib Impurity 45 | | Synonyms: | Tofacitinib Impurity 45;CP-690550 N-Hydroxyl;(3R,4R)-3-[(7-Hydroxy-7H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-1-piperidinepropanenitrile;Tofacitinib Impurity 172;1-Piperidinepropanenitrile, 3-[(7-hydroxy-7H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)- | | CAS: | 2407039-29-4 | | MF: | C16H20N6O2 | | MW: | 328.38 | | EINECS: | | | Product Categories: | | | Mol File: | 2407039-29-4.mol |  |
| | Tofacitinib Impurity 45 Chemical Properties |
| Melting point | >144°C (dec.) | | Boiling point | 625.5±65.0 °C(Predicted) | | density | 1.39±0.1 g/cm3(Predicted) | | storage temp. | -20°C Freezer, Under inert atmosphere | | solubility | DMSO (Slightly), Methanol (Slightly, Sonicated) | | form | Solid | | pka | 6.04±0.60(Predicted) | | color | Light Brown to Brown |
| | Tofacitinib Impurity 45 Usage And Synthesis |
| Uses | CP-690550 N-Hydroxyl is an impurity of CP-690550 (C781350), a pyrrolo[2,3-d]pyrimidine derivative, as Janus kinase inhibitor for treatment of rheumatoid arthritis. |
| | Tofacitinib Impurity 45 Preparation Products And Raw materials |
|